Biomednewsbreaks Renovorx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...
RenovoRx Announces $10.9 Million Public Offering of Common Stock
RenovoRx, Inc. (NASDAQ: RNXT) recently announced the execution of an underwriting agreement with Titan Partners Group LLC for a firm commitment underwritten public offering of its common stock. The ...
MassDevice6d
RenovoRx prices $12.1M offering
RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...
RenovoRx Announces Pricing of $12.1 Million Underwritten Public Offering of Common Stock
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery ...
Morningstar7d
RenovoRx Announces Proposed Public Offering
and its mission is to transform the lives of cancer patients by providing innovative solutions to enable targeted delivery of diagnostic and therapeutic agents. RenovoRx’s Phase III lead product ...
WFMZ-TV2d
$1M from the state prevented this rural hospital from closing, but its troubles aren’t over
RENOVO, Pa. — Tracy Bruno had just ordered ... said the current health care system isn’t sustainable “without innovative solutions.” The center’s work focuses on improving access to ...
spotlightpa22d
$1M from the state prevented this rural hospital from closing, but its troubles aren’t over
RENOVO — Tracy Bruno had just ordered breakfast at Socky ... said the current health care system isn’t sustainable “without innovative solutions.” The center’s work focuses on improving access to ...